Max Robotics — Global Service Robot Directory + US Certification

About

Germana Lissidini is a pioneering breast surgeon whose work is redefining the landscape of surgical oncology. Her primary research focus is the advancement and clinical validation of robotic mastectomy, a minimally invasive technique that promises better cosmetic outcomes and faster recovery for breast cancer patients. Lissidini's major contributions are anchored in rigorous clinical trials, most notably her landmark 2021 randomized trial comparing robotic mastectomy to open surgery in women with breast cancer or BRCA mutations. This study, which has garnered over 100 citations, provided critical evidence on the safety, efficacy, and quality-of-life benefits of the robotic approach. She has also authored comprehensive reviews, including a 2019 update on the feasibility of robotic breast surgery and a 2023 forward-looking piece declaring it the "next major advance" in the field. Through these works, Lissidini has established herself as a leading voice in the shift toward less invasive, patient-centered surgical techniques, directly influencing how surgeons worldwide approach mastectomy.